Moderna Balance Sheet Health
Financial Health criteria checks 6/6
Moderna has a total shareholder equity of $13.9B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $18.4B and $4.6B respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.60b |
| Equity | US$13.85b |
| Total liabilities | US$4.57b |
| Total assets | US$18.43b |
Recent financial health updates
No updates
Recent updates
Moderna: Considering The Cancer Vaccine Angle
Apr 11Moderna Continues To Build A Pipeline
Apr 03Lukewarm Reaction To Moderna's Vaccine Day Sums Up Fine Margins In Play
Mar 27Moderna, Inc. (NASDAQ:MRNA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Feb 27
Moderna: Counting On Pipeline Too Much
Feb 23Moderna: Highly Uncertain Future For mRNA Vaccine In A Post-Pandemic World
Feb 16Moderna: Fade 2025 Outlook
Jan 15Moderna, Inc. (NASDAQ:MRNA) Held Back By Insufficient Growth Even After Shares Climb 26%
Dec 29Need To Know: The Consensus Just Cut Its Moderna, Inc. (NASDAQ:MRNA) Estimates For 2024
Nov 03Moderna, Inc. (NASDAQ:MRNA) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 18Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 47% Discount?
May 23Weak Statutory Earnings May Not Tell The Whole Story For Moderna (NASDAQ:MRNA)
Mar 03Financial Position Analysis
Short Term Liabilities: MRNA's short term assets ($10.3B) exceed its short term liabilities ($3.0B).
Long Term Liabilities: MRNA's short term assets ($10.3B) exceed its long term liabilities ($1.6B).
Debt to Equity History and Analysis
Debt Level: MRNA is debt free.
Reducing Debt: MRNA had no debt 5 years ago.
Debt Coverage: MRNA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MRNA has no debt, therefore coverage of interest payments is not a concern.